Literature DB >> 8738511

Biology of interleukin-5 and its relevance to allergic disease.

R W Egan1, S P Umland, F M Cuss, R W Chapman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8738511     DOI： 10.1111/j.1398-9995.1996.tb04561.x

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  9 in total

1.  Effect of IL-5, glucocorticoid, and Fas ligation on Bcl-2 homologue expression and caspase activation in circulating human eosinophils.

Authors:  J Zangrilli; N Robertson; A Shetty; J Wu; A Hastie; J E Fish; G Litwack; S P Peters
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

Review 2.  The new histologic classification of chronic rhinosinusitis.

Authors:  Sonya Malekzadeh; John F McGuire
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

3.  Human eosinophil-airway smooth muscle cell interactions.

Authors:  J M Hughes; C A Arthur; S Baracho; S M Carlin; K M Hawker; P R Johnson; C L Armour
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

4.  Enzyme linked immuno-spot; a useful tool in the search for elusive immune markers in common pediatric immunological diseases.

Authors:  Maria Faresjö
Journal:  Cells       Date:  2012-05-29       Impact factor: 6.600

5.  Analysis of Cynandione A's Anti-Ischemic Stroke Effects from Pathways and Protein-Protein Interactome.

Authors:  Haiyang Fang; Rongcai Yue; Yang Ga; Yi Zhang; Lei Shan; Jing Zhao
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

6.  Role and Significance of Markers of Inflammation in the Asthmatic Disease.

Authors:  Zlatica Goseva; Elena Jovanovska Janeva; Angelko Gjorcev; Zoran Arsovski; Sava Pejkovska
Journal:  Open Access Maced J Med Sci       Date:  2015-10-21

Review 7.  An algorithmic approach for the treatment of severe uncontrolled asthma.

Authors:  Eleftherios Zervas; Konstantinos Samitas; Andriana I Papaioannou; Petros Bakakos; Stelios Loukides; Mina Gaga
Journal:  ERJ Open Res       Date:  2018-03-06

8.  Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma.

Authors:  Garry M Walsh
Journal:  Biologics       Date:  2013-01-09

9.  Antagonism of cytokine-induced eosinophil accumulation in asthma.

Authors:  Garry M Walsh
Journal:  Front Pharmacol       Date:  2012-11-22       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.